loading...| Preferred Name |
COVID-19 |
|
| Synonyms |
SARS CoV 2 Infection COVID 19 Pandemic |
|
| Definitions |
A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000086382 |
|
| altLabel |
SARS CoV 2 Infection Coronavirus Disease 2019 Severe Acute Respiratory Syndrome Coronavirus 2 Infection COVID 19 Virus Infection Infection, 2019-nCoV 2019-nCoV Infection COVID-19 Virus Diseases COVID 19 Virus Disease 2019 Novel Coronavirus Disease Coronavirus Disease-19 Coronavirus Disease 19 COVID19 Disease, COVID-19 Virus Infection, SARS-CoV-2 SARS Coronavirus 2 Infection COVID-19 Pandemics 2019-nCoV Diseases Pandemic, COVID-19 COVID-19 Virus Disease COVID 19 SARS-CoV-2 Infection 2019 nCoV Infection Infection, COVID-19 Virus 2019 nCoV Disease Disease, 2019-nCoV Virus Disease, COVID-19 2019-nCoV Disease COVID-19 Virus Infection SARS-CoV-2 Infections 2019-nCoV Infections 2019 Novel Coronavirus Infection Virus Infection, COVID-19 COVID-19 Pandemic Disease 2019, Coronavirus COVID-19 Virus Infections COVID 19 Pandemic |
|
| AQL |
BL CF CI CL CN CO DG DH DI EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH TM UR VE VI |
|
| cui |
C5203670 C5392141 |
|
| DC |
1 |
|
| definition |
A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. |
|
| DX |
20210101 |
|
| EC |
drug therapy:COVID-19 Drug Treatment |
|
| FX |
D000086402 |
|
| HN |
2021(2020) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000178 http://purl.bioontology.org/ontology/MESH/Q000175 http://purl.bioontology.org/ontology/MESH/Q000628 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000139 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000517 http://purl.bioontology.org/ontology/MESH/Q000662 http://purl.bioontology.org/ontology/MESH/Q000469 http://purl.bioontology.org/ontology/MESH/Q000151 http://purl.bioontology.org/ontology/MESH/Q000150 http://purl.bioontology.org/ontology/MESH/Q000821 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000196 http://purl.bioontology.org/ontology/MESH/Q000473 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000382 http://purl.bioontology.org/ontology/MESH/Q000451 http://purl.bioontology.org/ontology/MESH/Q000453 http://purl.bioontology.org/ontology/MESH/Q000534 http://purl.bioontology.org/ontology/MESH/Q000532 http://purl.bioontology.org/ontology/MESH/Q000503 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000201 http://purl.bioontology.org/ontology/MESH/Q000209 http://purl.bioontology.org/ontology/MESH/Q000208 http://purl.bioontology.org/ontology/MESH/Q000635 http://purl.bioontology.org/ontology/MESH/Q000601 http://purl.bioontology.org/ontology/MESH/Q000000981 http://purl.bioontology.org/ontology/MESH/Q000652 |
|
| Inverse of RO | ||
| Machine permutation |
2021; for COVID-19 see PNEUMONIA, VIRAL; CORONAVIRUS INFECTIONS; and PANDEMICS 2020 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C000722978 http://purl.bioontology.org/ontology/MESH/C000705967 http://purl.bioontology.org/ontology/MESH/C000718087 http://purl.bioontology.org/ontology/MESH/C000711430 http://purl.bioontology.org/ontology/MESH/C000718127 |
|
| MDA |
20200707 |
|
| MMR |
20220714 |
|
| MN |
C01.748.610.763.500 C08.381.677.807.500 C01.925.782.600.550.200.163 C01.925.705.500 C08.730.610.763.500 |
|
| notation |
D000086382 |
|
| prefLabel |
COVID-19 |
|
| TERMUI |
T001082223 T001079527 T001079529 T001079526 T001079544 T001079530 T001102616 T001079531 T001079528 T001007916 T001007884 T001079532 T001079546 T001079547 T001079545 |
|
| TH |
NLM (2020) NLM (2022) NLM (2021) |
|
| tui |
T047 T067 |
|
| subClassOf |